Ge, T., Jhala, G., Fynch, S., Akazawa, S., Litwak, S., Pappas, E.G., Catterall, T., Vakil, I., Long, A.J., Olson, L.M., Krishnamurthy, B., Kay, T.W. and Thomas, H.E. (2020) The JAK1 Selective Inhibitor ABT 317 Blocks Signaling Through Interferon-γ and Common γ Chain Cytokine Receptors to Reverse Autoimmune Diabetes in NOD Mice. Frontiers in Immunology, 11, Article ID: 588543.
https://doi.org/10.3389/fimmu.2020.588543

has been cited by the following article: